Hedge funds gained 3.08% in March, according to the Barclay Hedge Fund Index compiled by BarclayHedge.
“Global stock indices reached new highs for the year as economic data continued to suggest that a recovery is underway,” said Sol Waksman, founder and president of BarclayHedge.
“On average, emerging market equity indices gained 8.04% in March, and developed market indices gained 6.29%.”
All but one of Barclay’s 18 hedge fund indices had a positive return in March. The Barclay healthcare and biotechnology index soared 5.15%, emerging markets jumped 5.23%, equity long bias was up 4.03%, distressed securities gained 3.79%, technology was up 3.85%, and Pacific Rim equities gained 3.84%.
“Nearly 87% of the funds reporting their March return to BarclayHedge have recorded a profit for the month,” said Waksman.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.